The present teaching relates to methods and systems for associating information with carriers for supporting biological reagents. During the manufacture and use of biological reagents, the reagents are typically coded and labeled in order to keep track of them. Conventional systems use bar codes to identify carriers containing reagents to be processed by analytical instrumentation. Bar codes, however, require printing and application of a bar code label to carriers for the biological reagents. At some later time the bar code is read by either a hand-held bar code scanner or by an automated bar-code scanner controlled by the instrumentation to track the reagents as they are processed.
To read a label or a barcode, however, requires an optical path to the barcode, which can be inconvenient and problematic, for example if the indicia to be read are located inside of an instrument. In the past these problems have been addressed by forming windows in the instruments or carriers to provide an optical path to the labels. Such windows can complicate the design of instruments and carriers and depending on the configuration and design of a particular window, the optical path can be distorted, resulting in optical reading and scanning problems. Further reading problems can result from printing inconsistencies and any material that covers the bar code, such as frost in a refrigerator.
Further, if information needs to be added to a label associated with a particular sample, physical access is required to print the additional information to the label. Moreover, only a limited amount of information can be printed on a label associated with a carrier due to label space limitations. When using bar codes, 1-D and 2-D bar codes are limited as to how much information can be printed in a given amount of space by the visual resolution between marks. Therefore, typically a printed carrier number or identifier is used as an index into a database of information regarding the carrier or the contents of the carrier. The database was typically provided on a separate CDROM or other removable machine-readable medium. However, it can be inconvenient to associate the information on particular CDROM with a particular carrier.
Vincogen Corporation of Trevose, Pa. purports to have filed U.S. patent application Ser. No. 10/396,269, on using RFID technology in connection with biochips to provide an identifier number for such biochips. However, the Vincogen product fails to address the above-identified deficiencies of existing methods and systems.
Accordingly, systems and methods are needed that provide for the reading from and writing to carriers for biological reagents without requiring an optical path or direct physical access to the carriers. Moreover, there is need for storing greater amounts of information than can be written on a conventional label.
According to various embodiments, apparatus is provided for associating information with a biological reagent according to the present teachings. The apparatus can include a carrier for supporting the biological reagent and at least one RFID tag including a carrier RFID antenna coupled to the carrier, wherein the RFID tag is operable to be read by an RFID reader, and the RFID tag can include identification, supplemental, and/or rights information for the biological reagent.
According to various embodiments, apparatus is provided for associating information with a microarray according to the present teachings. The apparatus can include a substrate; at least one chamber coupled to the microarray; and an RFID tag having an RFID antenna coupled to the substrate.
According to various embodiments, apparatus is provided for associating information with a biological reagent according to the present teachings. The apparatus can include a carrier for the biological reagent. The carrier is coupled to an RFID tag, and the RFID tag is operable to be read by an RFID reader. The RFID tag contains identification information. Further, an instrument is provided for reading the identification information, and performing operations on the biological reagent, the instrument including an output for providing an identity indication of the biological reagent based on the identification information. The instrument is generally opaque and blocks optical paths to contents of the instrument.
According to various embodiments, the present teachings involve methods for associating information regarding biological reagents with carriers for supporting the biological reagents. A carrier for the biological reagents is provided, and the carrier is coupled to an RFID tag so that the RFID tag can be read by an RFID reader. Identification, supplemental, and/or, rights information associated with the biological reagent is received from the RFID tag.
According to various embodiments, apparatus for associating information with a biological reagent is provided. The apparatus includes a carrier for supporting the biological reagent and an RFID tag including a carrier RFID antenna coupled to the carrier. The RFID tag can be read by an RFID reader, and the RFID tag includes instrument operation information for the biological reagent.
According to various embodiments, a method for associating information regarding operations for biological reagents with carriers for supporting the biological reagents is provided. The method includes providing a carrier for at least one biological reagent, the carrier coupled to an RFID tag, which can be read by an RFID reader. The method also includes receiving, from the RFID tag, instrument operation information associated with the biological reagent.
It is understood that both the foregoing general description and the following description of various embodiments are exemplary and explanatory only and are not meant to be restrictive or to be read into the claims. The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate some embodiments, and together with the description serve to explain the principles of the embodiments described herein.
The skilled artisan will understand that the drawings, described below, are only intended for the illustration of various embodiments. The drawings are not intended to limit the scope of the present teachings in any way.
Reference will now be made in detail to some embodiments, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers are used throughout the drawings to refer to the same or like parts.
Radio Frequency Identification (“RFID”) provides a convenient mechanism for identifying and detecting objects using wireless electro-magnetic signals. A basic RFID system has at least one RFID reader and at least one RFID tag. Typically, RFID readers can include a coil or antenna and circuitry to transmit and receive signals with the coil or antenna. An RFID tag also includes a coil or antenna and some information that can be read by an RFID reader.
The RFID reader antenna generates an electromagnetic field, thereby transferring energy to the tag. Depending on the design of the tag, a portion of the energy transferred to the tag will be reflected to the reader so as to provide information about the tag back to the reader. Some RFID systems can be used to read and optionally write data to and from the RFID tag. RFID readers can generate signals spanning distances from less than one inch to more than 100 feet depending on frequency and power of the signals generated at the RFID reader antenna.
Typically, RFID tags are categorized as either active or passive. Active RFID tags are powered by an internal battery and are typically read/write, i.e., tag data can be rewritten and/or modified. An active tag's memory size varies according to application requirements; some systems operate with up to 1 MB of memory.
Passive RFID tags operate without a separate external power source and obtain operating power generated from the reader. Passive tags are consequently typically lighter than active tags, less expensive, and offer a long operational lifetime. Passive tags typically have shorter read ranges than active tags and require a higher-powered reader. Read-only tags are typically passive and can be programmed with a unique set of data (usually 32 to 128 bits) that is typically predetermined at the time of manufacture of the tag. It is understood that passive read/write tags can also be employed consistent with the present teachings.
The term “RFID tag” as used herein refers to either an active or passive RFID tag that contains information. The RFID tag can be read only or read/write, and the information associated with the RFID tag can be hard-coded into the RFID tag at the time of manufacture or at some later time, or the RFID tag can contain information that is written to the RFID tag throughout its lifetime.
The term “RFID reader” as used herein includes RFID devices that can read information from and/or write information into an RFID tag.
The term “carrier” as used herein refers to a structure for directly or indirectly supporting a biological reagent. Examples of carriers include reaction plates, tubes, tube carriers, surface plasmon resonance arrays, slides, conical low-volume tubes, microfluidic cards, microarray cartridges, microarrays, and other types of containers for supporting biological reagents.
The term “biological reagent” as used herein refers to a biological material used for various biological analyses such as detecting, examining, and/or measuring information from biological samples. Biological analyses can include reactions such as polymerase chain reaction (PCR), ligase chain reaction, antibody binding reaction, oligonucleotide ligation assays, and hybridization assays. Examples of biological reagents include nucleic acids, primers, probes, and other biological reagents, which can be used in performing various biological assays. “Nucleic acid” as used herein refers to nucleotides, oligonucleotides, DNA, RNA, PNA, etc. as these terms are understood by those skilled in the art of genomics.
The term “information” as used herein refers to data that can be stored electronically in the RFID tag and can be retrieved to be used as machine readable or human readable data for processing the biological reagent and/or carrier.
The term “identification information” as used herein refers to information on an RFID tag that can be used to uniquely identify a particular carrier or biological reagent or to distinguish the carrier or biological reagent from other carriers or biological reagents. For example, identification can relate a particular assay prepared for a particular customer.
The term “supplemental information” as used herein refers to descriptive information about a carrier or its contents, including certain biological reagents. Examples of supplemental information include nucleic acid sequence information and annotated information regarding experiments performed with various biological reagents.
The term “rights information” as used herein refers to authorization information for carriers or biological reagents, such as information regarding whether a particular licensee has a valid license to use a particular carrier or biological reagent, including a number of times the licensee is permitted to use the particular carrier or biological reagent in a particular assay. Rights information can also include validation information regarding whether a particular carrier or biological reagent has been subject to a recall or has otherwise become unsuitable or unauthorized for use.
The term “genealogy information” as used herein refers to information regarding the derivation of a biological reagent, including for example an identification of an original sample from which it was derived or the number of generations removed it is from an original sample.
The term “traveler information” as used herein refers to information regarding a carrier or a biological reagent contained as operations are performed on that carrier or biological reagent for example during manufacture of the biological reagent or while an assay is being performed on the biological reagent.
According to various embodiments, the reaction plates contain biological reagents such as nucleic acid materials, primers, and probes, which are used in connection with various biological assays to determine, for example a genetic sequence of a particular sample. In various embodiments, separate RFID tags on the plate are associated with groups of wells within the reaction plate. In other embodiments, an RFID tag is associated with a single well in the reaction plate 100. In other embodiments, a single RFID tag is associated with the entire reaction plate, with the RFID tag containing information regarding each of the wells and the contents and history of the contents of each of the well. In such embodiments, a read/write RFID tag containing a substantial amount of memory can include, for example, identification, supplemental, and/or rights information about the contents of the wells 102 (of
According to various embodiments, no read/write RFID tag is directly coupled to a particular tube. Rather, the tube bears a simplified RFID tag or optical indicia that provides, for example, row and column information for the tube's position in the tube carrier 400. Then, for example, information regarding the contents of tubes can be stored in a more complex RFID tag that is affixed to or embedded into the tube carrier 400, either at the lid 402 or at the carrier base 404. Alternatively, additional information can be stored on a CDROM or other removable medium and associated with each tube, for example, based on a unique identifier on the RFID tag associated with the tube or tube carrier. The additional information can also be provided in an encrypted on-line database, as further set forth in connection with
Exemplary RFID tag positions are illustrated in connection with
According to various embodiments, the tube carrier 400 can contain a simplified RFID tag containing only an identifier number, which is cross-referenced to a table that contains information on the contents of particular tubes 300 in the particular tube carrier 400. In various embodiments, the lookup table information is provided on removable, machine-readable media, such as CDROM. In various other embodiments, the lookup table information is provided in the form of a network-accessible, on-line database. In various ones of these embodiments, the lookup table information is encrypted either in an off-line CDROM-type form or in an on-line form.
According to various embodiments, authentication and/or decryption information can be stored in the RFID tag or tags on or in the tubes 300 and/or the tube carrier 400. It is understood that any type of digital authentication and/or cryptography system can be employed to provide access to and decryption for the on-line or off-line data associated with the biological contents of the carriers without departing from the scope of the present teachings.
As described above in connection with other consumables, the RFID tags 602 and 604 can be affixed to an outer surface of the SPR array 600 (as shown with RFID tag 602) or embedded in the SPR array during manufacture (as shown with RFID 604). In various embodiments the SPR array is constructed from a standard glass slide which has a layer of gold deposited to an underside surface of the slide, and the RFID tag is adhesively applied to an upper surface 610 of the glass slide.
According to various embodiments, information regarding the contents of the chambers and/or the contents loaded into the card can be provided. Accordingly, RFID tags consistent with the present teachings are affixed to a surface of a portion of the microfluidic card 800 for example on surface 804 as shown in connection with RFID tag 806. The RFID tag 808 is shown as being embedded into a portion of the microfluidic card 800. It is understood that the RFID tag can be affixed to or embedded in other portions of the card, such as the supporting lid portion 802, which has a plurality of apertures, through which the chambers 814 can be observed by an instrument to determine the results of an assay performed in connection with the microfluidic card 800. The RFID tag 806 can include information regarding specific assays preloaded into the microfluidic card. Further, the RFID tag 806 can include information regarding samples injected into the card, which is written to the RFID tag as the samples are being injected into the card.
According to various embodiments, information can be stored in RFID tags associated with any of the above-described consumables that can be useful, for example, in the transportation of the biological reagents. For example, in connection with the importation and/or exportation of biological reagents, biological reagent content information and country of origin information can be provided consistent with the present teachings. National customs agencies typically require the provision of such country of origin information during import and/or export of various biological reagents. It is understood that the provision of such information by way of an RFID reader interface would drastically expedite the provision to customs authorities of, for example, country of origin information for various biological reagents.
According to various embodiments, Material Safety Data Sheet (MSDS) information can be stored in the RFID tags and read at any time during the lifecycle of the biological reagent while it is contained in or supported by a carrier consistent with the present teachings.
According to various embodiments, the information stored in the RFID tags associated with the biological reagents can include traveler information that is written to the RFID tag at various stages or steps along the course of a biological assay. In various embodiments, genealogy data is read and used during the course of an assay.
According to various embodiments, biological samples or reagents that are provided in the carriers described above are licensed separately from instruments designed to operate on the biological reagents. In various embodiments the instruments are coupled to a network (see e.g.
According to various embodiments, when an RFID tag is read by an instrument that has access to a data network that includes a connection to information regarding biological reagent recall information, the instrument can perform a database lookup to determine whether the biological reagent has been subject to a recall. The recall information and an optional last recall check date and/or timestamp can be written to the RFID tag. In various embodiments, a recall database lookup is performed each time before a biological reagent is utilized in an assay or other test such as, for example a clinical diagnostic procedure.
According to various embodiments, external displays are provided to display information regarding the biological reagent contents of a consumable when the biological reagent is inside of an instrument or other container, such as a refrigerator. For example when a microarray is contained within its microarray cartridge, an RFID reader can read the identification information from the microarray and display it on a human readable interface, such as a computer terminal, LCD, or other type of display.
Via a network connection 1105, the instrument 1106, and/or the general purpose computer 1110 can be connected to a public or private network, such as internet 1104. It is understood that any networking technology can be employed without departing from the present teachings, including wired and wireless networking technologies. It is also understood that, in various embodiments, the network connection associated with the instrument 1106 can emanate from the instrument 1106 as shown or from the general purpose computer 1110.
By employing a network connection, the instrument 1106 and/or its associated general purpose computer 1110 can remotely access databases 1120, 1130, 1140, and 1150 via remote network connections 1103. In various embodiments, information contained in the databases 1120, 1130, 1140, and 1150 can be written to the RFID tag 1209 as set forth below in connection with
According to various embodiments, the instrument 1106 includes instrument hardware, instrument firmware, instrument data acquisition and control software, and method or module data. In various embodiments, the instrument hardware includes electronic control and data processing circuitry, such as a microprocessor or microcontroller, memory, and non-volatile storage. In various embodiments, the instrument hardware also includes physical devices to manipulate biological reagents such as robotics and sample pumps. In various embodiments, the instrument firmware includes low-level, computer-readable instructions for carrying out basic operations in connection with the instrument hardware. In various embodiments, the instrument firmware includes microprocessor instructions for initializing operations on a microprocessor in the instrument hardware.
According to various embodiments, the instrument data acquisition and control software is higher-level software that interfaces with the instrument firmware to control the instrument hardware for more specific operations such as operating a charge coupled device (CCD) to acquire visual luminescence information regarding a particular biological analysis. In various embodiments the data acquisition and control software includes a software-implemented state machine providing, for example, the following states: (i) idle; (ii) running; (iii) paused; and (iv) error. In various embodiments, when the state machine is in the idle state, it can receive an instruction from the general purpose machine 1110 to perform a particular data acquisition or instrument control operation. In various embodiments, the general purpose computer 1110 opens a TCP/IP socket connection to the instrument 1106, determines whether the instrument 1106 is in the idle state and then begins transmitting instructions and/or parameters. In various embodiments, an encrypted TCP/IP connection is established, using, for example, the SSH protocol. The instructions and/or parameters can be in the form of ASCII encoded, human readable module and/or method information that defines the behavior of the biological instrument. In various embodiments, the modules and/or methods are stored in the form of ASCII text files. In various embodiments, the general purpose computer 1110 uses the FTP protocol to transfer the ASCII text files to the instrument 1106. In various other embodiments the method and/or module information is stored in and read from the RFID tag 1109. The method and/or module information can be stored in the form of an ASCII text file in the RFID tag 1109, but it is understood that the information can be represented in other data formats without departing from the present teachings. In various embodiments, methods and module information is stored in a relational database, such as those available from the Oracle Corporation of Redwood Shores, Calif.
According to various embodiments, the module, macro, and/or method information includes parameters that can be used by the instrument data acquisition and control software to perform specific data acquisition and instrument control operations. In various embodiments, the method and/or module information contains sequences of operations to be performed by the instrument or control parameters for use in connection with the data acquisition or control software.
The section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described in any way.
All literature and similar materials cited in this application, including but not limited to, patents, patent applications, articles, books, treatises, and internet web pages, regardless of the format of such literature and similar materials, are expressly incorporated by reference in their entirety for any purpose.
While the present teachings are described in conjunction with various embodiments, it is not intended that the present teachings be limited to such embodiments. On the contrary, the present teachings encompass various alternatives, modifications, and equivalents, as will be appreciated by those of skill in the art.
This application is a divisional of U.S. patent application Ser. No. 14/536,451 filed Nov. 7, 2014, which is a continuation of U.S. patent application Ser. No. 14/163,270 filed Jan. 24, 2014, now U.S. Pat. No. 9,019,079, which is a continuation of U.S. patent application Ser. No. 13/689,288 filed Nov. 29, 2012, now U.S. Pat. No. 8,669,849, which is a continuation of U.S. patent application Ser. No. 13/689,267 filed Nov. 29, 2012, now U.S. Pat. No. 8,665,071, which is a continuation of U.S. patent application Ser. No. 13/615,070 filed Sep. 13, 2012, now U.S. Pat. No. 8,669,848, which is a continuation of U.S. patent application Ser. No. 13/253,535 filed Oct. 5, 2011, now U.S. Pat. No. 8,400,304, which is a continuation of U.S. patent application Ser. No. 13/014,366 filed Jan. 26, 2011, now U.S. Pat. No. 8,049,623, which is a continuation of U.S. patent application Ser. No. 12/164,890 filed Jun. 30, 2008, now U.S. Pat. No. 7,880,617, which is a continuation of U.S. patent application Ser. No. 11/647,065 filed Dec. 28, 2006, now U.S. Pat. No. 7,663,487, which is a continuation of U.S. patent application Ser. No. 10/805,093 filed Mar. 19, 2004, now U.S. Pat. No. 7,187,286, all of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3549406 | Ambusk | Dec 1970 | A |
3888759 | Elson et al. | Jun 1975 | A |
3960499 | White | Jun 1976 | A |
4006069 | Hiratsuka et al. | Feb 1977 | A |
4072639 | Yamaguchi et al. | Feb 1978 | A |
4094759 | Ruhenstroth-Bauer et al. | Jun 1978 | A |
4246092 | Mordechai et al. | Jun 1981 | A |
4411490 | Daniel | Oct 1983 | A |
4415418 | Turre et al. | Nov 1983 | A |
4415428 | Nochumson et al. | Nov 1983 | A |
4418098 | Maistrovich et al. | Nov 1983 | A |
4548869 | Ogawa et al. | Oct 1985 | A |
4548870 | Ogawa et al. | Oct 1985 | A |
4569794 | Smith et al. | Feb 1986 | A |
4579783 | Ogawa et al. | Apr 1986 | A |
4600641 | Ogawa et al. | Jul 1986 | A |
4717667 | Provochee | Jan 1988 | A |
4718998 | Ogawa et al. | Jan 1988 | A |
4737259 | Ogawa et al. | Apr 1988 | A |
4908112 | Pace | Mar 1990 | A |
4915811 | Yamamoto et al. | Apr 1990 | A |
4929972 | Anderson et al. | May 1990 | A |
5055517 | Shorr et al. | Oct 1991 | A |
5128412 | Miyasaka et al. | Jul 1992 | A |
5190632 | Fujimiya et al. | Mar 1993 | A |
5212299 | Smith | May 1993 | A |
5219923 | Shorr | Jul 1993 | A |
5225212 | Martin et al. | Jul 1993 | A |
5238651 | Chuba | Aug 1993 | A |
5252294 | Kroy et al. | Oct 1993 | A |
5306468 | Anderson et al. | Apr 1994 | A |
5384028 | Ito | Jan 1995 | A |
5395619 | Zalipsky | Mar 1995 | A |
5397449 | Zewert et al. | Mar 1995 | A |
5455344 | Harper et al. | Oct 1995 | A |
5476016 | Fedorka-Cray et al. | Dec 1995 | A |
5498324 | Yeung et al. | Mar 1996 | A |
5585069 | Zanzucchi et al. | Dec 1996 | A |
5641626 | Dumais et al. | Jun 1997 | A |
5641634 | Mandecki | Jun 1997 | A |
5641400 | Kaltenbach et al. | Jul 1997 | A |
5670226 | Yoshizawa et al. | Sep 1997 | A |
5672416 | Radola et al. | Sep 1997 | A |
5681437 | Black et al. | Oct 1997 | A |
5700429 | Buhler et al. | Dec 1997 | A |
5741462 | Nova et al. | Apr 1998 | A |
5751629 | Nova et al. | May 1998 | A |
5764892 | Cain et al. | Jun 1998 | A |
5770455 | Cargill et al. | Jun 1998 | A |
5779868 | Parce et al. | Jul 1998 | A |
5817472 | Hardham et al. | Oct 1998 | A |
5840877 | Kozulic | Nov 1998 | A |
5851370 | Maracas et al. | Dec 1998 | A |
5851488 | Saul et al. | Dec 1998 | A |
5859587 | Alicot et al. | Jan 1999 | A |
5874214 | Nova et al. | Feb 1999 | A |
5882679 | Needham | Mar 1999 | A |
5883376 | Rosch et al. | Mar 1999 | A |
5885432 | Hooper et al. | Mar 1999 | A |
5910287 | Cassin et al. | Jun 1999 | A |
5925562 | Nova et al. | Jul 1999 | A |
5949049 | McCarrick | Sep 1999 | A |
5953682 | McCarrick et al. | Sep 1999 | A |
5954931 | Maracas et al. | Sep 1999 | A |
5962834 | Markman | Oct 1999 | A |
5990238 | DiZio et al. | Nov 1999 | A |
5993627 | Anderson et al. | Nov 1999 | A |
6013168 | Arai | Jan 2000 | A |
6017434 | Simpson et al. | Jan 2000 | A |
6017624 | Delgado et al. | Jan 2000 | A |
6025129 | Nova et al. | Feb 2000 | A |
6027695 | Oldenburg et al. | Feb 2000 | A |
6031458 | Jacobsen et al. | Feb 2000 | A |
6060022 | Pang et al. | May 2000 | A |
6071394 | Cheng et al. | Jun 2000 | A |
6085603 | Riekkinen | Jul 2000 | A |
6090251 | Sundberg et al. | Jul 2000 | A |
6090255 | Riley et al. | Jul 2000 | A |
6094137 | Rasch et al. | Jul 2000 | A |
6103199 | Bjornson et al. | Aug 2000 | A |
6112152 | Tuttle | Aug 2000 | A |
6123821 | Anderson et al. | Sep 2000 | A |
6132685 | Kercso et al. | Oct 2000 | A |
6136173 | Anderson et al. | Oct 2000 | A |
6139709 | Scott | Oct 2000 | A |
6140146 | Brady et al. | Oct 2000 | A |
6147662 | Grabau | Nov 2000 | A |
6149058 | Albaret | Nov 2000 | A |
6171780 | Pham et al. | Jan 2001 | B1 |
6187250 | Champagne | Feb 2001 | B1 |
6201474 | Brady et al. | Mar 2001 | B1 |
6206292 | Robertz et al. | Mar 2001 | B1 |
6211781 | McDonald | Apr 2001 | B1 |
6219137 | Vo-Dinh | Apr 2001 | B1 |
6245206 | Anderson et al. | Jun 2001 | B1 |
6251516 | Bonner et al. | Jun 2001 | B1 |
6258606 | Kovacs | Jul 2001 | B1 |
6259367 | Klein | Jul 2001 | B1 |
6277630 | Brophy et al. | Aug 2001 | B1 |
6278794 | Parekh et al. | Aug 2001 | B1 |
6280590 | Cheng | Aug 2001 | B1 |
6297727 | Nelson, Jr. | Oct 2001 | B1 |
6300141 | Segal et al. | Oct 2001 | B1 |
6317028 | Valiulis | Nov 2001 | B1 |
6317208 | Hirosawa | Nov 2001 | B1 |
6319668 | Nova et al. | Nov 2001 | B1 |
6329139 | Nova et al. | Dec 2001 | B1 |
6352854 | Nova et al. | Mar 2002 | B1 |
6359444 | Grimes | Mar 2002 | B1 |
6361950 | Mandecki | Mar 2002 | B1 |
6372428 | Nova et al. | Apr 2002 | B1 |
6376187 | Mandecki | Apr 2002 | B1 |
6387623 | Mandecki | May 2002 | B1 |
6416714 | Nova et al. | Jul 2002 | B1 |
6417010 | Cargil et al. | Jul 2002 | B1 |
6429016 | McNeil | Aug 2002 | B1 |
6454924 | Jedrzejewski et al. | Sep 2002 | B2 |
6458259 | Parce et al. | Oct 2002 | B1 |
6483434 | UmiKer | Nov 2002 | B1 |
6520544 | Mitchell et al. | Feb 2003 | B1 |
6521111 | Amshey | Feb 2003 | B1 |
6535129 | Petrick | Mar 2003 | B1 |
6541211 | Patek | Apr 2003 | B1 |
6586143 | Tan | Jul 2003 | B1 |
6637473 | Ganz et al. | Oct 2003 | B2 |
6649403 | McDevitt | Nov 2003 | B1 |
6652812 | Vartiainen | Nov 2003 | B1 |
6670609 | Franzen et al. | Dec 2003 | B2 |
6677852 | Landt | Jan 2004 | B1 |
6686158 | Mandecki | Feb 2004 | B2 |
6699437 | Astle | Mar 2004 | B1 |
6726820 | Frazier | Apr 2004 | B1 |
6733728 | Mimura et al. | May 2004 | B1 |
6734797 | Shanks et al. | May 2004 | B2 |
6806050 | Zhou | Oct 2004 | B2 |
6824738 | Neeper et al. | Nov 2004 | B1 |
6824740 | Sheldon, III et al. | Nov 2004 | B1 |
6847912 | Forster | Jan 2005 | B2 |
6858439 | Xu | Feb 2005 | B1 |
6867048 | Kovacs | Mar 2005 | B2 |
6881314 | Wang et al. | Apr 2005 | B1 |
6887362 | Huang et al. | May 2005 | B2 |
6889468 | Bedingham et al. | May 2005 | B2 |
6906797 | Kao et al. | Jun 2005 | B1 |
6917291 | Allen | Jul 2005 | B2 |
6928353 | Finley et al. | Aug 2005 | B2 |
6934836 | Strand et al. | Aug 2005 | B2 |
6935560 | Andreasson et al. | Aug 2005 | B2 |
6942778 | Jalali | Sep 2005 | B1 |
6953834 | Dejong | Oct 2005 | B1 |
6982640 | Lindsay et al. | Jan 2006 | B2 |
6986836 | Panattoni et al. | Jan 2006 | B2 |
7053777 | Allen | May 2006 | B2 |
7061379 | Chen et al. | Jun 2006 | B2 |
7083106 | Albany | Aug 2006 | B2 |
7091864 | Veitch et al. | Aug 2006 | B2 |
7113131 | Burke | Sep 2006 | B2 |
7118708 | Mordekhay | Oct 2006 | B2 |
7142987 | Eggers | Nov 2006 | B2 |
7153403 | Alpenfels et al. | Dec 2006 | B2 |
7187286 | Morris et al. | Mar 2007 | B2 |
7298885 | Green et al. | Nov 2007 | B2 |
7338811 | Derhsing | Mar 2008 | B2 |
7361260 | Amshey et al. | Apr 2008 | B2 |
7382258 | Oldham et al. | Jun 2008 | B2 |
7390458 | Burow et al. | Jun 2008 | B2 |
7663487 | Morris et al. | Feb 2010 | B2 |
7880617 | Morris et al. | Feb 2011 | B2 |
8049623 | Morris et al. | Nov 2011 | B2 |
8059623 | Gandham | Nov 2011 | B2 |
8400304 | Morris et al. | Mar 2013 | B2 |
8665071 | Morris et al. | Mar 2014 | B2 |
8669848 | Morris et al. | Mar 2014 | B2 |
8669849 | Morris et al. | Mar 2014 | B2 |
8890706 | Sattler | Nov 2014 | B2 |
9019079 | Morris et al. | Apr 2015 | B2 |
9530035 | Morris et al. | Dec 2016 | B2 |
9545221 | Adhikari | Jan 2017 | B2 |
20010008390 | Berquist et al. | Jul 2001 | A1 |
20010021356 | Konrad | Sep 2001 | A1 |
20020018733 | Kapplein et al. | Feb 2002 | A1 |
20020030598 | Dombrowski | Mar 2002 | A1 |
20020052238 | Muroi | May 2002 | A1 |
20020076819 | Bowman et al. | Jun 2002 | A1 |
20020077886 | Chung | Jun 2002 | A1 |
20020090320 | Burow et al. | Jul 2002 | A1 |
20020094515 | Erlach et al. | Jul 2002 | A1 |
20020098472 | Erlach | Jul 2002 | A1 |
20020098598 | Coffen et al. | Jul 2002 | A1 |
20020111551 | Erlach et al. | Aug 2002 | A1 |
20020114739 | Weigl et al. | Aug 2002 | A1 |
20030017082 | Van Deursen et al. | Jan 2003 | A1 |
20030058110 | Rich | Mar 2003 | A1 |
20030072676 | Fletcher-Hayes et al. | Apr 2003 | A1 |
20030087446 | Eggers et al. | May 2003 | A1 |
20030087455 | Eggers et al. | May 2003 | A1 |
20030087955 | Miller et al. | May 2003 | A1 |
20030124539 | Warrington et al. | Jul 2003 | A1 |
20030151028 | Lawrence et al. | Aug 2003 | A1 |
20030183683 | Stewart | Oct 2003 | A1 |
20030196897 | Alpenfels et al. | Oct 2003 | A1 |
20030211012 | Bergstrom et al. | Nov 2003 | A1 |
20030217925 | Alpenfels et al. | Nov 2003 | A1 |
20030231986 | Kocher | Dec 2003 | A1 |
20040029109 | Lai | Feb 2004 | A1 |
20040029310 | Bernds et al. | Feb 2004 | A1 |
20040094949 | Savagian et al. | May 2004 | A1 |
20040100380 | Lindsay et al. | May 2004 | A1 |
20040100415 | Veitch et al. | May 2004 | A1 |
20040101966 | Davis et al. | May 2004 | A1 |
20040121432 | Klein et al. | Jun 2004 | A1 |
20040124437 | Doudoumopolous | Jul 2004 | A1 |
20040131505 | Koeda | Jul 2004 | A1 |
20040133092 | Kain | Jul 2004 | A1 |
20040136873 | Meier | Jul 2004 | A1 |
20040155754 | Fischer et al. | Aug 2004 | A1 |
20040161795 | Marto | Aug 2004 | A1 |
20040172160 | O'Dougherty et al. | Sep 2004 | A1 |
20040173508 | Deursen et al. | Sep 2004 | A1 |
20040173781 | Lawrence et al. | Sep 2004 | A1 |
20040175515 | Lawrence et al. | Sep 2004 | A1 |
20040175548 | Lawrence et al. | Sep 2004 | A1 |
20040175550 | Lawrence et al. | Sep 2004 | A1 |
20040193449 | Wildman et al. | Sep 2004 | A1 |
20040195102 | Panattoni et al. | Oct 2004 | A1 |
20040202577 | McNeil et al. | Oct 2004 | A1 |
20040203047 | Caren et al. | Oct 2004 | A1 |
20040222297 | Dearing et al. | Nov 2004 | A1 |
20050159982 | Showalter et al. | Jul 2005 | A1 |
20050219039 | Allen | Oct 2005 | A1 |
20050242963 | Oldham et al. | Nov 2005 | A1 |
20050276728 | Muller-Cohn | Dec 2005 | A1 |
20060099567 | Muller Cohn | May 2006 | A1 |
20060173750 | Naley | Aug 2006 | A1 |
20060190185 | Ford et al. | Aug 2006 | A1 |
20060199196 | O'Banion et al. | Sep 2006 | A1 |
20060283945 | Excoffier | Dec 2006 | A1 |
20080235055 | Mattingly et al. | Sep 2008 | A1 |
20080237043 | Amshey et al. | Oct 2008 | A1 |
20090071829 | O'Banion et al. | Mar 2009 | A1 |
20100262379 | Frazier | Oct 2010 | A1 |
20100307921 | Frazier et al. | Dec 2010 | A1 |
20110001609 | Oldham et al. | Jan 2011 | A1 |
Number | Date | Country |
---|---|---|
3032069 | Jun 1982 | DE |
3032071 | Jul 1982 | DE |
3032070 | Oct 1982 | DE |
0376611 | Jul 1990 | EP |
01257255 | Oct 1989 | JP |
H09-111198 | Apr 1997 | JP |
2001-188061 | Jul 2001 | JP |
2003-289566 | Oct 2003 | JP |
2004-061136 | Feb 2004 | JP |
2004-093519 | Mar 2004 | JP |
2004-166555 | Jun 2004 | JP |
2004-246492 | Sep 2004 | JP |
2011-511238 | Apr 2011 | JP |
1996008433 | Mar 1996 | WO |
1996036436 | Nov 1996 | WO |
1998059092 | Dec 1998 | WO |
2001047638 | Jul 2001 | WO |
2005040500 | May 2005 | WO |
2005113147 | Dec 2005 | WO |
2006060125 | Jun 2006 | WO |
Entry |
---|
International Search Report and Written Opinion, international Application No. PCT/US05/40500, dated May 30, 2007. |
Pharmaseq, “Illustration of a microtransponder for DNA-probe assays”, http://www.pharmaseq.com/illustration.html, downloaded Sep. 23, 2004. |
Sambrook, Joseph., et al., “Introduction of Recombinant Vectors into Mammalian Cells”, Molecular Cloning: a Laboratory Manual, 1989, pp. 16.30-16.60, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. |
Service, Robert F., “Radio Tags Speed Compound Synthesis”, Research News, Chemistry, Science, Oct. 27, 1995, p. 577, vol. 270. |
Tam, Robert C., et al., “Biological availability and nuclease resistance extend the in vitro activity of a phosphoraothioate-3′hydroxypropylamine oligonucleotide”, Nucleic Acids Research, 1994, pp. 977-986, vol. 22—No. 6, Oxford University Press. |
Taylor, Lisa D., et al., “Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM”, International Immunology, 1994, pp. 579-591, vol. 6—No. 4, Oxford University Press. |
Ward, Sally E., et al., “Binding activities of a repertoire of single immunoqlobulin variable domains secreted from Escherichia coli”, Letters to Nature, Nature, Oct. 12, 1989, pp. 544-546, vol. 341, Nature Publishing Group. |
Winter, Greg, et al., “Humanized antibodies.”, Immunology Today, 1993, pp. 243-246, vol. 14—No. 6, Elsevier Science Publications, Ltd, UK. |
Winter, Greg, et al., “Making antibodies by Phage Display Technology.”, Annu. Rev. Immunol, 1994, pp. 433-455, vol. 12, Annual Reviews Inc. |
Zebra Technologies, “RFID: The Next Generation of AIDC”, Application White Paper, Aug. 2004, pp. 1-13, Rev. 7, ZIH Corp., Vernon Hills, IL. |
Zebra Technologies, “Zebra's RFID Readiness Guide: Complying with RFID Tagging Mandates”, Application White Paper, Jan. 2004, pp. 1-9, ZIH Corp., Vernon Hills, IL. |
US 7,165,720, 1/2007, Linton et al. (withdrawn) |
Dupont, DuPont Nucrel, Products and Services, 2006, http://www.dupont.com/industrial-polymers/nucrel/. |
Lonza, GelBond Film: Casting Agarose Gels on GelBond Film, 2007, Lonza Rockland, Inc. http://www.bioproducts.com/product . . . . |
Lonza, GelBond PAG Film, 2007, Lonza Rockland, Inc., http://www.bioproducts.com/product . . . . |
Vincogen, “Investors Relationship”, Jan. 28, 2004, Vincogen Corporation, http://www.vincogen.com/Investor/.htm. |
VGD LLC, “Membrane Filters”, http://www.voigtglobal.com/membfil.htm. |
“New RFID Tag with More Memory”, News, RFID Journal, Aug. 25, 2003, RFID Journal Inc. |
SPI Supplies, “Polycarbonate Membrane Filters”, SPI-Pore and Nuclepore brands, 1995-1999, Contracting Structure Probe, Inc., http://www.2spi.com/catalog/spec_prep/filter3.html. |
“Report: RFID Labels”, Williams Inference Center, Sep. 28, 2000, vol. 27—No. 15, Longmeadow, MA. |
AIM, “Radio Frequency Identification RFID”, A basic primer, The Association of the Automatic Identification and Data Capture Industry, Aug. 23, 2001, pp. 1-17, AIM Inc. Pittsburgh, PA. |
Vincogen, “Technology:”, Jan. 28, 2004, Vincogen Corporation, http://www.vincogen.com/technologmyl.htm. |
Intermec, “The Write Stuff: Understanding the Value of Read/Write RFID Functionality”, 2003, pp. 1-4, Intermec Technologies Corporation, USA. |
Ausubel, Frederick M., et al., “Current Protocols in Molecular Biology”, Table of Contents, 1994-1998, pp. 1-12, vol. 1—supplement 63, John Wiley & Sons, Inc. |
Baines, Michael G., et al., “Purification of Immunoglobulin G (IgG)”, Chapter 8, vol. 10: Immunochemical Protocols, Methods in Molecular Biology, 1992, pp. 79-104, The Humana Press, Inc., Totowa, NJ. |
Barbas III, Carlos F., et al., “Combinatorial Immunoglobulin Libraries on the Surface of Phage (Phabs): Rapid Selection of Antigen-Specific Fabs”, METHODS: A Companion to Methods in Enzymology, Apr. 1991, pp. 119-124, vol. 2—No. 2, Academic Press, Inc. |
Birge, Robert R., “Protein-Based Three Dimensional Memory”, American Scientist, Jul.-Aug. 1994, pp. 348-355, vol. 82. |
Birge, Robert R., et al., “Biomolecular Electronics: Protein-Based Associative Processors and Volumetric Memories”, Feature Article, J. Phvs. Chem. B, Sep. 3, 1999, pp. 10746-10766, vol. 103—No. 49, American Chemical Society. |
Borrabeck, Carl A.K., “Antibody Engineering”, 1995, Second Edition, Oxford University Press. |
Brush, Michael, “Prepare to Cast Off: A Profile of Precast Acrylamide Gels”, Profile, The Scientist, Jul. 20, 1998, 12[15]:18, The Scientist, Inc. |
Cooper, Helen M., et al., “Production of Antibodies”, Current Protocols in Immunology, 1995, pp. 2.4.1-2.4.9, Supplement 13, Section II—Unit 2.4, John Wiley & Sons, Inc. |
Ecker, David J., et al., “Combinatorial Drug Discovery: Which Methods Will Produce the Greatest Value?”, Review, Biotechnology, Apr. 1995, pp. 351-360, vol. 13. |
Supplementary European Search Report and European Search Opinion, European Application No. EP 05 851 446.4, dated Mar. 22, 2012, 8 pages. |
Supplementary European Search Report, European Application No. EP 01 93 1132.3, dated Aug. 14, 2008, 3 pages. |
Flotte, Terence R., “Prospects for Virus-Based Gene Therapy for Cystic Fibrosis”, Journal of Bioenergetics and Biomembranes, 1993, pp. 37-42, vol. 25. |
Fraley, Robert, et al., “New generation liposomes: the engineering of an efficient vehicle for intracellular delivery of nucleic acids”, TIBS, Mar. 1981, pp. 77-80, vol. 6. |
Frost, Pam, “Tiny Channels Carved In Plastic Enable Medical Test on a CD”, Ohio State Research News, 2000, The Ohio State University, Columbus, OH, www.osu.edu/units/research. |
Goeddel, David V., “Gene Expression Technology”, Table of Contents, Methods in Enxymology, 1990, vol. 185, Academic Press, Inc., San Diego, CA. |
Green, Jonathan A., et al., “Production of Polyclonal Antisera”, Chapter 1, Immunochemical Protocols, Methods in Molecular Biology, 1992, pp. 1-5, vol. 10, The Humana Press, Inc., Totowa, NJ. |
Green, L.L., et al., “Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs”, article, Nature Genetics, May 1994, pp. 13-21, vol. 7. |
Gregoriadis Ph.D., Gregory, “Preparation of Liposomes”, Liposomes Technology, Table of Contents, 1984, vol. 1, CFC Press, Inc., Boca Raton, FL. |
Harlow, Ed, et al., “Sampling Serum”, Chapter 5: Immunizations, Antibodies: A Laboratory Manual, 1988, pp. 116-120, 2nd Edition, Cold Spring Harbor Laboratory, USA. |
Henke, Cliff, “DNA-chip technologies, Part 1: Research fundamentals and industry catalysts”, IVD Technology Magazine, IVDT Article Index, Sep. 1998. |
Henke, Cliff, “DNA-chip technologies Part 2: State-of-the-art and competing technologies”, IVD Technology Magazine, IVDT Article Index, Nov. 1998. |
Henke, Cliff, “DNA-chip technologies Part 3: What does the future hold?”, IVD Technology Magazine, IVDT Article Index. |
Huse, William D., et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”, Research Article, Science, Dec. 8, 1989, pp. 1275-1281, vol. 246. |
Jellinek, Derek, et al., “Potent 2′-Amino-2′-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor”, Biochemistry, 1995, pp. 11363-11372, vol. 34—No. 36, American Chemical Society. |
Jolly, Douglas, et al., “Viral vector systems for gene therapy”, Review Article, Cancer Gene Therapy, 1994, pp. 51-64, vol. 1—No. 1, Appleton & Lange. |
Kambil, Ajit, “Move Over Barcodes; Consumer-Goods Firms Eye Radio-Frequency ID”, A Deloitte Research Emerging Technologies Brief, 2003, pp. 1-5, Deloitte Consulting. |
Kohler, G. et al., Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, Aug. 7, 1975, pp. 495-497, vol. 256. |
Kuchinskas, Susan, “IP Addresses for Coke Cans?”, Ecommerce News, Sep. 5, 2003, earthwebnews.com. |
Lee, Ph.D., Youbok, “Antenna Circuit Design for RFID Applications”, Microchip AN710, 2003, pp. 1-50, Microchip Technology Inc., USA. |
Lin, Yun, et al., “Modified RNA sequence pools for in vitro selection”, Nucleic Acids Research, 1994, pp. 5229-5234, vol. 22—No. 24, Oxford University Press. |
Lonberg, Nils, et al., “Antigen-specific human antibodies from mice comprising four distinct genetic modifications”, Letters to Nature, Nature, Apr. 28, 1994, pp. 856-859, vol. 368. |
Michael, Sharon I., et al., “Binding-incompetent Adenovirus Facilitates Molecular Conjugate-mediated Gene Transfer by the Receptor-mediated Endocytosis Pathway”, The Journal of Biological Chemistry, Apr. 1993, pp. 6866-6869, vol. 268—No. 10, The American Society for Biochemistry and Molecular Biology, Inc., USA. |
Moran, Edmund J., et al., “Radio Frequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide-Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase PTP1B”, Communications to the Editor, J. Am. Chem. Soc., 1995, pp. 10787-10788, vol. 117, American Chemical Society. |
Morishita, Ryuichi, et al., “Novel and Effective Gene Transfer Technique for Study of Vascular Renin Anglotensin System”, J. Clin. Invest., Jun. 1993, pp. 2580-2585, vol. 91, The American Society for Clinical Investigation, Inc. |
Pagratis, Nikos C., et al., “Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor”, Research, Nature Biotechnology, Jan. 1997, pp. 68-73, vol. 15. |
“International Search Report”, International Application No. PCT/US01/40489, dated Jul. 6, 2001. |
“International Preliminary Report on Patentability and Written Opinion”, International Application No. PCT/US05/40500, dated Jul. 19, 2007. |
Number | Date | Country | |
---|---|---|---|
20170087555 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14536451 | Nov 2014 | US |
Child | 15375953 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14163270 | Jan 2014 | US |
Child | 14536451 | US | |
Parent | 13689288 | Nov 2012 | US |
Child | 14163270 | US | |
Parent | 13689267 | Nov 2012 | US |
Child | 13689288 | US | |
Parent | 13615070 | Sep 2012 | US |
Child | 13689267 | US | |
Parent | 13253535 | Oct 2011 | US |
Child | 13615070 | US | |
Parent | 13014366 | Jan 2011 | US |
Child | 13253535 | US | |
Parent | 12164890 | Jun 2008 | US |
Child | 13014366 | US | |
Parent | 11647065 | Dec 2006 | US |
Child | 12164890 | US | |
Parent | 10805093 | Mar 2004 | US |
Child | 11647065 | US |